LV11899B - Jauni adenozīna atvasinājumi, to iegūšanas paņēmiens - Google Patents

Jauni adenozīna atvasinājumi, to iegūšanas paņēmiens Download PDF

Info

Publication number
LV11899B
LV11899B LVP-97-128A LV970128A LV11899B LV 11899 B LV11899 B LV 11899B LV 970128 A LV970128 A LV 970128A LV 11899 B LV11899 B LV 11899B
Authority
LV
Latvia
Prior art keywords
formula
exemple
lower alkyl
indole
une
Prior art date
Application number
LVP-97-128A
Other languages
English (en)
Latvian (lv)
Other versions
LV11899A (lv
Inventor
Nicole Bru-Magniez
Timur Gungor
Jean-Marie Teulon
Original Assignee
Laboratoires Upsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Upsa filed Critical Laboratoires Upsa
Publication of LV11899A publication Critical patent/LV11899A/xx
Publication of LV11899B publication Critical patent/LV11899B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-97-128A 1992-01-08 1997-06-25 Jauni adenozīna atvasinājumi, to iegūšanas paņēmiens LV11899B (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200138A FR2685918B1 (fr) 1992-01-08 1992-01-08 Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
LV11899A LV11899A (lv) 1997-12-20
LV11899B true LV11899B (lv) 1998-03-20

Family

ID=9425478

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-128A LV11899B (lv) 1992-01-08 1997-06-25 Jauni adenozīna atvasinājumi, to iegūšanas paņēmiens

Country Status (25)

Country Link
US (2) US5229505A (hu)
EP (1) EP0623138B1 (hu)
JP (1) JP3224542B2 (hu)
KR (1) KR100232672B1 (hu)
AT (1) ATE153342T1 (hu)
AU (1) AU661894B2 (hu)
CA (1) CA2127472C (hu)
CZ (1) CZ289047B6 (hu)
DE (1) DE69219901T2 (hu)
DK (1) DK0623138T3 (hu)
EE (1) EE03087B1 (hu)
ES (1) ES2105285T3 (hu)
FI (1) FI106205B (hu)
FR (1) FR2685918B1 (hu)
GE (1) GEP19981357B (hu)
GR (1) GR3024386T3 (hu)
HU (1) HU221304B1 (hu)
LV (1) LV11899B (hu)
MD (1) MD502G2 (hu)
NZ (1) NZ246904A (hu)
RU (1) RU2129560C1 (hu)
SK (1) SK282205B6 (hu)
TW (1) TW254945B (hu)
UA (1) UA44221C2 (hu)
WO (1) WO1993014102A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2714907B1 (fr) * 1994-01-07 1996-03-29 Union Pharma Scient Appl Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
WO1995018817A1 (fr) * 1994-01-07 1995-07-13 Laboratoires Upsa Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
FR2772271B1 (fr) * 1997-12-11 2000-09-01 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
CN1313861A (zh) 1998-06-23 2001-09-19 葛兰素集团有限公司 2－(嘌呤－9－基)－四氢呋喃－3,4－二醇衍生物
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
ES2332869T3 (es) * 1999-11-17 2010-02-15 Boston Scientific Limited Dispositivos microfabricados para la entrega de moleculas en fluidos portadores.
WO2002020539A1 (fr) * 2000-09-08 2002-03-14 Toa Eiyo Ltd. Derives d'adenosine et leur utilisation
EP1352910A1 (en) * 2002-04-10 2003-10-15 Grünenthal GmbH New analogs of nitrobenzylthioinosine
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
WO1988003148A2 (en) * 1986-10-31 1988-05-05 Warner-Lambert Company Heteroaromatic derivatives of adenoside
WO1988003147A1 (en) * 1986-10-31 1988-05-05 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
EP0267878A1 (en) * 1986-11-14 1988-05-18 Ciba-Geigy Ag N9-cyclopentyl-substituted adenine derivatives
SU1661367A1 (ru) * 1988-11-01 1991-07-07 Всесоюзный научно-исследовательский институт по креплению скважин и буровым растворам Способ гидрофобизации тампонажных материалов
ES2095960T3 (es) * 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
FR2685918B1 (fr) 1995-06-23
GEP19981357B (en) 1998-08-25
ATE153342T1 (de) 1997-06-15
HU9402040D0 (en) 1994-09-28
FR2685918A1 (fr) 1993-07-09
CZ164394A3 (en) 1995-02-15
HUT68095A (en) 1995-05-29
US5229505A (en) 1993-07-20
FI106205B (fi) 2000-12-15
SK81894A3 (en) 1995-04-12
EP0623138A1 (fr) 1994-11-09
ES2105285T3 (es) 1997-10-16
FI943222A (fi) 1994-08-18
DK0623138T3 (da) 1997-12-15
EE03087B1 (et) 1998-04-15
JP3224542B2 (ja) 2001-10-29
WO1993014102A1 (fr) 1993-07-22
CA2127472C (en) 2003-11-18
KR100232672B1 (ko) 1999-12-01
AU661894B2 (en) 1995-08-10
SK282205B6 (sk) 2001-12-03
EP0623138B1 (fr) 1997-05-21
RU2129560C1 (ru) 1999-04-27
FI943222A0 (fi) 1994-07-06
US5480983A (en) 1996-01-02
CA2127472A1 (en) 1993-07-22
DE69219901T2 (de) 1997-11-13
AU3455093A (en) 1993-08-03
HU221304B1 (en) 2002-09-28
MD502F1 (en) 1996-03-29
CZ289047B6 (cs) 2001-10-17
GR3024386T3 (en) 1997-11-28
RU94039545A (ru) 1997-04-27
LV11899A (lv) 1997-12-20
MD502G2 (ro) 1996-11-30
TW254945B (hu) 1995-08-21
JPH07502738A (ja) 1995-03-23
NZ246904A (en) 1995-04-27
UA44221C2 (uk) 2002-02-15
DE69219901D1 (de) 1997-06-26

Similar Documents

Publication Publication Date Title
JP3171850B2 (ja) アミジノ誘導体およびその一酸化窒素シンターゼ阻害剤としての使用
LV11899B (lv) Jauni adenozīna atvasinājumi, to iegūšanas paņēmiens
FR2714907A1 (fr) Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
US4684747A (en) N,N'-bis(sulfonyl)hydrazines having antineoplastic activity
JP2009530401A5 (hu)
HU177104B (en) Process for preparing 5'-deoxy-5-fluoro-cytidine and -uridine
JPH07107066B2 (ja) 置換インドキノキサリン類
JPH06508854A (ja) 新規のアデノシン誘導体
CA2436958A1 (fr) Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation
JPH01308267A (ja) 新規なアリステロマイシン／アデノシン誘導体類
KR860001865B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
DE68923913T2 (de) Neplanocinderivate.
PT84923B (pt) Processo para a preparacao de derivados de 1-(hidroxiestiril)-5h-2,3-benzodiazepina e de composicoes farmaceuticas que os contem
US20080287390A1 (en) Pyrazolidinol compounds
EP0117196B1 (fr) Nouveaux dérivés de bétaines n-iminopyridinium, leur préparation et leur application en tant que médicaments
WO1995018817A1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
US4892887A (en) N,N'-bis(sulfonyl)hydrazines having antineoplastic activity
US3966916A (en) N(6)-disubstituted adenoisine compounds and therapeutic compositions
JPS6344577A (ja) ピリミジン誘導体
US7582616B2 (en) Nucleoside transport inhibitors
JPH01165586A (ja) 抗腫瘍プロドラッグ
US3925409A (en) 4-Aryl-1,2,3,4-tetrahydropyrrolo{8 3,4-b{9 indoles
JPH02503321A (ja) １，４‐置換‐２，３，５，６‐テトラヒドロ［１，３，６］トリアゾシノ［１，２‐ａ］‐ベンズイミダゾール類およびそのための中間体類
CA1265160A (en) Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza- dodecanes
JPH06172365A (ja) １０−チアイソアロキサジン誘導体およびその用途